foxo4 dri human clinical trial foxo4-dri peptide senolytic Molecular modelling of the FOXO4-TP53 interaction to design senolytic Frontiers | Senolytic Peptide FOXO4-DRI
Description
The different cell types (iPSCs, GF-HLCs, SM-HLCs and CTR) were analyzed by principal component analysis (PCA) which showed a significant overlap in the global protein abundance in the GF-HLC, SM-HLC and CTR
Moreover, the intestinal epithelial cells express receptors activated by SCFAs
EC 50 values for Van and Rif against intracellular MRSA strain JE2-lux were determined using GraphPad Prism
M.HeifetzA
